Trialect

+ More Filters

Reset Filters

Title

Funding Organization

Funding Type

Eligible Country

Deadline

Other (Select all that apply)

Show Expired Programs

Show Verified Programs

Verified

Novo Nordisk Prize 2025 (medical sciences | Europe)

Novo Nordisk Fonden

The Novo Nordisk Prize recognizes an active scientist who has provided outstanding international contributions to advance medical science for the benefit of people’s lives. The Prize is intended to award and further support biomedical research in Europe. The Prize is of DKK 5 million (appr. EUR 672,000) and consists of a DKK 4,5 million (appr. EUR 605,000) research grant and a personal award of DKK 0,5 million (appr. EUR 67,000).

The Foundation will grant an additional DKK 0,5 million for hosting an international symposium within the recipient’s field(s) of research.

Nominations

The nomination call is open until early August for the forthcoming year. The Foundation welcomes nominations by individual researchers and by research institutions including academic and industrial institutions, and research funding agencies. To be evaluated by the Novo Nordisk Prize Committee, nomination must be submitted electronically via the nomination form to be accessed here. The nomination and review processes are confidential.

Specialties

Biomedical Engineering

Others

Eligibility Requirements

Nominees must demonstrate scientific excellence that has led to a major discovery or breakthrough in understanding of human health and disease, prevention, diagnosis and/or treatment of the disease.
Nominees must have a current position and an active research program at a public, non-profit research institution and/or in a company based in a European country.
Nominees must serve as inspirational leaders and role models for young scientists.
Nominees may have any nationalities.
Nominators (individual or institution) are not limited in number of nominations.

Ineligibility:

Self-nominations are not accepted
Nominators cannot be family members
The prize may not be awarded to members of the Novo Nordisk Foundation Board or committee members or to Board members, directors or employees of the Novo Group.

The Novo Nordisk Prize Awardee will be announced in April 2025.

Sponsor Details

Sponsor Institute/Organizations: Novo Nordisk Fonden

Sponsor Type:

Address: Tuborg Havnevej 19 2900 Hellerup Denmark

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity